nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ACE—forelimb zeugopod—head and neck cancer	0.0354	0.372	CbGeAlD
Lisinopril—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00804	0.00888	CcSEcCtD
Lisinopril—ACE2—thyroid gland—head and neck cancer	0.00796	0.0836	CbGeAlD
Lisinopril—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00734	0.00811	CcSEcCtD
Lisinopril—Hepatic failure—Hydroxyurea—head and neck cancer	0.0073	0.00806	CcSEcCtD
Lisinopril—Renal failure acute—Hydroxyurea—head and neck cancer	0.0071	0.00785	CcSEcCtD
Lisinopril—ACE2—head—head and neck cancer	0.00706	0.0742	CbGeAlD
Lisinopril—Leukocytosis—Fluorouracil—head and neck cancer	0.00692	0.00764	CcSEcCtD
Lisinopril—Heartburn—Docetaxel—head and neck cancer	0.00682	0.00753	CcSEcCtD
Lisinopril—Throat sore—Docetaxel—head and neck cancer	0.00651	0.00719	CcSEcCtD
Lisinopril—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00645	0.00713	CcSEcCtD
Lisinopril—ACE—mouth—head and neck cancer	0.00639	0.0672	CbGeAlD
Lisinopril—Face oedema—Hydroxyurea—head and neck cancer	0.00633	0.00699	CcSEcCtD
Lisinopril—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00614	0.00679	CcSEcCtD
Lisinopril—Pleural effusion—Docetaxel—head and neck cancer	0.00613	0.00677	CcSEcCtD
Lisinopril—Photophobia—Fluorouracil—head and neck cancer	0.0061	0.00675	CcSEcCtD
Lisinopril—Angina pectoris—Vinblastine—head and neck cancer	0.00605	0.00669	CcSEcCtD
Lisinopril—Otitis media—Docetaxel—head and neck cancer	0.00603	0.00666	CcSEcCtD
Lisinopril—Breast disorder—Hydroxyurea—head and neck cancer	0.00592	0.00655	CcSEcCtD
Lisinopril—Pancytopenia—Vinblastine—head and neck cancer	0.0059	0.00652	CcSEcCtD
Lisinopril—Rhinorrhoea—Docetaxel—head and neck cancer	0.00579	0.0064	CcSEcCtD
Lisinopril—Pancreatitis—Hydroxyurea—head and neck cancer	0.00556	0.00614	CcSEcCtD
Lisinopril—Depression—Vinblastine—head and neck cancer	0.00552	0.00611	CcSEcCtD
Lisinopril—ACE—neck—head and neck cancer	0.00547	0.0574	CbGeAlD
Lisinopril—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00546	0.00604	CcSEcCtD
Lisinopril—Myocardial infarction—Vinblastine—head and neck cancer	0.00543	0.006	CcSEcCtD
Lisinopril—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00543	0.006	CcSEcCtD
Lisinopril—Pancytopenia—Hydroxyurea—head and neck cancer	0.00538	0.00595	CcSEcCtD
Lisinopril—Photosensitivity—Fluorouracil—head and neck cancer	0.00537	0.00594	CcSEcCtD
Lisinopril—Chest discomfort—Docetaxel—head and neck cancer	0.0053	0.00586	CcSEcCtD
Lisinopril—Dysuria—Hydroxyurea—head and neck cancer	0.0053	0.00586	CcSEcCtD
Lisinopril—Neutropenia—Hydroxyurea—head and neck cancer	0.0053	0.00586	CcSEcCtD
Lisinopril—SLC15A1—epithelium—head and neck cancer	0.00519	0.0545	CbGeAlD
Lisinopril—Agranulocytosis—Vinblastine—head and neck cancer	0.00517	0.00571	CcSEcCtD
Lisinopril—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00516	0.0057	CcSEcCtD
Lisinopril—Weight increased—Hydroxyurea—head and neck cancer	0.00516	0.0057	CcSEcCtD
Lisinopril—Oliguria—Docetaxel—head and neck cancer	0.00509	0.00563	CcSEcCtD
Lisinopril—Drug interaction—Docetaxel—head and neck cancer	0.00506	0.00559	CcSEcCtD
Lisinopril—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00495	0.00547	CcSEcCtD
Lisinopril—ACE2—lymph node—head and neck cancer	0.00494	0.0519	CbGeAlD
Lisinopril—Pharyngitis—Vinblastine—head and neck cancer	0.00494	0.00546	CcSEcCtD
Lisinopril—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00478	0.00528	CcSEcCtD
Lisinopril—Osteoarthritis—Fluorouracil—head and neck cancer	0.00472	0.00522	CcSEcCtD
Lisinopril—Pulmonary embolism—Docetaxel—head and neck cancer	0.00469	0.00519	CcSEcCtD
Lisinopril—Influenza like illness—Docetaxel—head and neck cancer	0.00456	0.00504	CcSEcCtD
Lisinopril—Hallucination—Hydroxyurea—head and neck cancer	0.00451	0.00499	CcSEcCtD
Lisinopril—Irritability—Fluorouracil—head and neck cancer	0.0045	0.00498	CcSEcCtD
Lisinopril—Cardiac arrest—Fluorouracil—head and neck cancer	0.00449	0.00496	CcSEcCtD
Lisinopril—Fluid retention—Docetaxel—head and neck cancer	0.00445	0.00492	CcSEcCtD
Lisinopril—Ataxia—Fluorouracil—head and neck cancer	0.00444	0.0049	CcSEcCtD
Lisinopril—Neuropathy—Docetaxel—head and neck cancer	0.00441	0.00487	CcSEcCtD
Lisinopril—Alopecia—Vinblastine—head and neck cancer	0.00439	0.00486	CcSEcCtD
Lisinopril—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00422	0.00466	CcSEcCtD
Lisinopril—Lightheadedness—Docetaxel—head and neck cancer	0.0042	0.00464	CcSEcCtD
Lisinopril—Pulmonary oedema—Docetaxel—head and neck cancer	0.00418	0.00462	CcSEcCtD
Lisinopril—Angiopathy—Hydroxyurea—head and neck cancer	0.00411	0.00455	CcSEcCtD
Lisinopril—Chills—Hydroxyurea—head and neck cancer	0.00407	0.0045	CcSEcCtD
Lisinopril—Eosinophilia—Fluorouracil—head and neck cancer	0.00404	0.00446	CcSEcCtD
Lisinopril—Ill-defined disorder—Vinblastine—head and neck cancer	0.00402	0.00444	CcSEcCtD
Lisinopril—Alopecia—Hydroxyurea—head and neck cancer	0.00401	0.00443	CcSEcCtD
Lisinopril—Anaemia—Vinblastine—head and neck cancer	0.004	0.00442	CcSEcCtD
Lisinopril—Angina pectoris—Fluorouracil—head and neck cancer	0.00397	0.00439	CcSEcCtD
Lisinopril—Erythema—Hydroxyurea—head and neck cancer	0.00395	0.00436	CcSEcCtD
Lisinopril—ACE—connective tissue—head and neck cancer	0.00392	0.0412	CbGeAlD
Lisinopril—Malaise—Vinblastine—head and neck cancer	0.0039	0.00431	CcSEcCtD
Lisinopril—Vertigo—Vinblastine—head and neck cancer	0.00389	0.0043	CcSEcCtD
Lisinopril—Leukopenia—Vinblastine—head and neck cancer	0.00388	0.00428	CcSEcCtD
Lisinopril—Pancytopenia—Fluorouracil—head and neck cancer	0.00387	0.00428	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00379	0.00419	CcSEcCtD
Lisinopril—Hepatic failure—Docetaxel—head and neck cancer	0.00379	0.00419	CcSEcCtD
Lisinopril—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00372	0.00411	CcSEcCtD
Lisinopril—ACE—epithelium—head and neck cancer	0.00372	0.0391	CbGeAlD
Lisinopril—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00366	0.00405	CcSEcCtD
Lisinopril—Pneumonia—Fluorouracil—head and neck cancer	0.00366	0.00404	CcSEcCtD
Lisinopril—Anaemia—Hydroxyurea—head and neck cancer	0.00365	0.00403	CcSEcCtD
Lisinopril—Discomfort—Vinblastine—head and neck cancer	0.00364	0.00402	CcSEcCtD
Lisinopril—Atrial fibrillation—Docetaxel—head and neck cancer	0.00359	0.00397	CcSEcCtD
Lisinopril—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00358	0.00396	CcSEcCtD
Lisinopril—Renal impairment—Docetaxel—head and neck cancer	0.00358	0.00396	CcSEcCtD
Lisinopril—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00356	0.00394	CcSEcCtD
Lisinopril—Myocardial infarction—Fluorouracil—head and neck cancer	0.00356	0.00394	CcSEcCtD
Lisinopril—Malaise—Hydroxyurea—head and neck cancer	0.00356	0.00393	CcSEcCtD
Lisinopril—Urinary tract infection—Fluorouracil—head and neck cancer	0.00353	0.00391	CcSEcCtD
Lisinopril—Leukopenia—Hydroxyurea—head and neck cancer	0.00353	0.00391	CcSEcCtD
Lisinopril—Thrombocytopenia—Vinblastine—head and neck cancer	0.00346	0.00382	CcSEcCtD
Lisinopril—Epistaxis—Fluorouracil—head and neck cancer	0.00343	0.00379	CcSEcCtD
Lisinopril—Hyponatraemia—Docetaxel—head and neck cancer	0.00342	0.00378	CcSEcCtD
Lisinopril—Sinusitis—Fluorouracil—head and neck cancer	0.00341	0.00377	CcSEcCtD
Lisinopril—Pain in extremity—Docetaxel—head and neck cancer	0.00341	0.00376	CcSEcCtD
Lisinopril—Agranulocytosis—Fluorouracil—head and neck cancer	0.00339	0.00375	CcSEcCtD
Lisinopril—Anorexia—Vinblastine—head and neck cancer	0.00337	0.00372	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00334	0.00369	CcSEcCtD
Lisinopril—Discomfort—Hydroxyurea—head and neck cancer	0.00332	0.00367	CcSEcCtD
Lisinopril—Rhinitis—Fluorouracil—head and neck cancer	0.00327	0.00362	CcSEcCtD
Lisinopril—Pharyngitis—Fluorouracil—head and neck cancer	0.00324	0.00358	CcSEcCtD
Lisinopril—Oedema—Hydroxyurea—head and neck cancer	0.00322	0.00356	CcSEcCtD
Lisinopril—Ataxia—Docetaxel—head and neck cancer	0.0032	0.00354	CcSEcCtD
Lisinopril—Infection—Hydroxyurea—head and neck cancer	0.0032	0.00354	CcSEcCtD
Lisinopril—Paraesthesia—Vinblastine—head and neck cancer	0.00317	0.00351	CcSEcCtD
Lisinopril—Dehydration—Docetaxel—head and neck cancer	0.00317	0.0035	CcSEcCtD
Lisinopril—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00315	0.00349	CcSEcCtD
Lisinopril—Skin disorder—Hydroxyurea—head and neck cancer	0.00313	0.00346	CcSEcCtD
Lisinopril—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00311	0.00344	CcSEcCtD
Lisinopril—Breast disorder—Docetaxel—head and neck cancer	0.00308	0.0034	CcSEcCtD
Lisinopril—Anorexia—Hydroxyurea—head and neck cancer	0.00307	0.00339	CcSEcCtD
Lisinopril—Decreased appetite—Vinblastine—head and neck cancer	0.00307	0.00339	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00307	0.00339	CcSEcCtD
Lisinopril—Cramp muscle—Docetaxel—head and neck cancer	0.00307	0.00339	CcSEcCtD
Lisinopril—Nasopharyngitis—Docetaxel—head and neck cancer	0.00305	0.00337	CcSEcCtD
Lisinopril—Pain—Vinblastine—head and neck cancer	0.00302	0.00334	CcSEcCtD
Lisinopril—Constipation—Vinblastine—head and neck cancer	0.00302	0.00334	CcSEcCtD
Lisinopril—Arrhythmia—Fluorouracil—head and neck cancer	0.00292	0.00322	CcSEcCtD
Lisinopril—Feeling abnormal—Vinblastine—head and neck cancer	0.00291	0.00322	CcSEcCtD
Lisinopril—Bronchospasm—Docetaxel—head and neck cancer	0.0029	0.0032	CcSEcCtD
Lisinopril—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00289	0.00319	CcSEcCtD
Lisinopril—Alopecia—Fluorouracil—head and neck cancer	0.00288	0.00319	CcSEcCtD
Lisinopril—Dyspnoea—Hydroxyurea—head and neck cancer	0.00287	0.00317	CcSEcCtD
Lisinopril—Angina pectoris—Docetaxel—head and neck cancer	0.00287	0.00317	CcSEcCtD
Lisinopril—Somnolence—Hydroxyurea—head and neck cancer	0.00286	0.00317	CcSEcCtD
Lisinopril—ACE—lymphoid tissue—head and neck cancer	0.00286	0.0301	CbGeAlD
Lisinopril—Erythema—Fluorouracil—head and neck cancer	0.00284	0.00314	CcSEcCtD
Lisinopril—Dyspepsia—Hydroxyurea—head and neck cancer	0.00284	0.00313	CcSEcCtD
Lisinopril—Decreased appetite—Hydroxyurea—head and neck cancer	0.0028	0.0031	CcSEcCtD
Lisinopril—Pancytopenia—Docetaxel—head and neck cancer	0.0028	0.00309	CcSEcCtD
Lisinopril—Abdominal pain—Vinblastine—head and neck cancer	0.00279	0.00309	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00278	0.00307	CcSEcCtD
Lisinopril—Fatigue—Hydroxyurea—head and neck cancer	0.00278	0.00307	CcSEcCtD
Lisinopril—Pain—Hydroxyurea—head and neck cancer	0.00276	0.00305	CcSEcCtD
Lisinopril—Constipation—Hydroxyurea—head and neck cancer	0.00276	0.00305	CcSEcCtD
Lisinopril—Neutropenia—Docetaxel—head and neck cancer	0.00275	0.00304	CcSEcCtD
Lisinopril—Weight increased—Docetaxel—head and neck cancer	0.00268	0.00296	CcSEcCtD
Lisinopril—Vision blurred—Fluorouracil—head and neck cancer	0.00268	0.00296	CcSEcCtD
Lisinopril—Weight decreased—Docetaxel—head and neck cancer	0.00266	0.00294	CcSEcCtD
Lisinopril—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00266	0.00293	CcSEcCtD
Lisinopril—Pneumonia—Docetaxel—head and neck cancer	0.00264	0.00292	CcSEcCtD
Lisinopril—Anaemia—Fluorouracil—head and neck cancer	0.00263	0.0029	CcSEcCtD
Lisinopril—Hypersensitivity—Vinblastine—head and neck cancer	0.0026	0.00288	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.0026	0.00288	CcSEcCtD
Lisinopril—ACE—thyroid gland—head and neck cancer	0.0026	0.0273	CbGeAlD
Lisinopril—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00259	0.00286	CcSEcCtD
Lisinopril—Renal failure—Docetaxel—head and neck cancer	0.00258	0.00285	CcSEcCtD
Lisinopril—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00257	0.00284	CcSEcCtD
Lisinopril—Myocardial infarction—Docetaxel—head and neck cancer	0.00257	0.00284	CcSEcCtD
Lisinopril—Jaundice—Docetaxel—head and neck cancer	0.00256	0.00283	CcSEcCtD
Lisinopril—Body temperature increased—Hydroxyurea—head and neck cancer	0.00255	0.00282	CcSEcCtD
Lisinopril—Leukopenia—Fluorouracil—head and neck cancer	0.00254	0.00281	CcSEcCtD
Lisinopril—Asthenia—Vinblastine—head and neck cancer	0.00254	0.0028	CcSEcCtD
Lisinopril—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00248	0.00274	CcSEcCtD
Lisinopril—Epistaxis—Docetaxel—head and neck cancer	0.00248	0.00274	CcSEcCtD
Lisinopril—Agranulocytosis—Docetaxel—head and neck cancer	0.00245	0.00271	CcSEcCtD
Lisinopril—Chest pain—Fluorouracil—head and neck cancer	0.00242	0.00267	CcSEcCtD
Lisinopril—Myalgia—Fluorouracil—head and neck cancer	0.00242	0.00267	CcSEcCtD
Lisinopril—Diarrhoea—Vinblastine—head and neck cancer	0.00242	0.00267	CcSEcCtD
Lisinopril—Discomfort—Fluorouracil—head and neck cancer	0.00239	0.00264	CcSEcCtD
Lisinopril—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00237	0.00262	CcSEcCtD
Lisinopril—Rhinitis—Docetaxel—head and neck cancer	0.00236	0.00261	CcSEcCtD
Lisinopril—Hepatitis—Docetaxel—head and neck cancer	0.00236	0.0026	CcSEcCtD
Lisinopril—Confusional state—Fluorouracil—head and neck cancer	0.00234	0.00258	CcSEcCtD
Lisinopril—Pharyngitis—Docetaxel—head and neck cancer	0.00234	0.00258	CcSEcCtD
Lisinopril—Dizziness—Vinblastine—head and neck cancer	0.00234	0.00258	CcSEcCtD
Lisinopril—Urinary tract disorder—Docetaxel—head and neck cancer	0.00233	0.00257	CcSEcCtD
Lisinopril—Oedema peripheral—Docetaxel—head and neck cancer	0.00232	0.00257	CcSEcCtD
Lisinopril—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00232	0.00256	CcSEcCtD
Lisinopril—Oedema—Fluorouracil—head and neck cancer	0.00232	0.00256	CcSEcCtD
Lisinopril—Asthenia—Hydroxyurea—head and neck cancer	0.00231	0.00256	CcSEcCtD
Lisinopril—Urethral disorder—Docetaxel—head and neck cancer	0.00231	0.00255	CcSEcCtD
Lisinopril—ACE—head—head and neck cancer	0.00231	0.0243	CbGeAlD
Lisinopril—Infection—Fluorouracil—head and neck cancer	0.0023	0.00255	CcSEcCtD
Lisinopril—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00227	0.00251	CcSEcCtD
Lisinopril—Tachycardia—Fluorouracil—head and neck cancer	0.00226	0.0025	CcSEcCtD
Lisinopril—Vomiting—Vinblastine—head and neck cancer	0.00225	0.00248	CcSEcCtD
Lisinopril—Erythema multiforme—Docetaxel—head and neck cancer	0.00223	0.00246	CcSEcCtD
Lisinopril—Headache—Vinblastine—head and neck cancer	0.00221	0.00245	CcSEcCtD
Lisinopril—Anorexia—Fluorouracil—head and neck cancer	0.00221	0.00244	CcSEcCtD
Lisinopril—Diarrhoea—Hydroxyurea—head and neck cancer	0.0022	0.00244	CcSEcCtD
Lisinopril—Flushing—Docetaxel—head and neck cancer	0.00219	0.00242	CcSEcCtD
Lisinopril—Hypotension—Fluorouracil—head and neck cancer	0.00217	0.0024	CcSEcCtD
Lisinopril—Angiopathy—Docetaxel—head and neck cancer	0.00214	0.00236	CcSEcCtD
Lisinopril—Dizziness—Hydroxyurea—head and neck cancer	0.00213	0.00235	CcSEcCtD
Lisinopril—Mediastinal disorder—Docetaxel—head and neck cancer	0.00212	0.00235	CcSEcCtD
Lisinopril—Chills—Docetaxel—head and neck cancer	0.00211	0.00234	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00211	0.00234	CcSEcCtD
Lisinopril—Arrhythmia—Docetaxel—head and neck cancer	0.0021	0.00233	CcSEcCtD
Lisinopril—Nausea—Vinblastine—head and neck cancer	0.0021	0.00232	CcSEcCtD
Lisinopril—Insomnia—Fluorouracil—head and neck cancer	0.0021	0.00232	CcSEcCtD
Lisinopril—Paraesthesia—Fluorouracil—head and neck cancer	0.00208	0.0023	CcSEcCtD
Lisinopril—Alopecia—Docetaxel—head and neck cancer	0.00208	0.0023	CcSEcCtD
Lisinopril—Dyspnoea—Fluorouracil—head and neck cancer	0.00207	0.00229	CcSEcCtD
Lisinopril—Mental disorder—Docetaxel—head and neck cancer	0.00206	0.00228	CcSEcCtD
Lisinopril—Somnolence—Fluorouracil—head and neck cancer	0.00206	0.00228	CcSEcCtD
Lisinopril—Erythema—Docetaxel—head and neck cancer	0.00205	0.00227	CcSEcCtD
Lisinopril—Malnutrition—Docetaxel—head and neck cancer	0.00205	0.00227	CcSEcCtD
Lisinopril—Vomiting—Hydroxyurea—head and neck cancer	0.00205	0.00226	CcSEcCtD
Lisinopril—Dyspepsia—Fluorouracil—head and neck cancer	0.00204	0.00226	CcSEcCtD
Lisinopril—Rash—Hydroxyurea—head and neck cancer	0.00203	0.00225	CcSEcCtD
Lisinopril—Dermatitis—Hydroxyurea—head and neck cancer	0.00203	0.00224	CcSEcCtD
Lisinopril—Headache—Hydroxyurea—head and neck cancer	0.00202	0.00223	CcSEcCtD
Lisinopril—Decreased appetite—Fluorouracil—head and neck cancer	0.00202	0.00223	CcSEcCtD
Lisinopril—Dysgeusia—Docetaxel—head and neck cancer	0.00201	0.00222	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.002	0.00221	CcSEcCtD
Lisinopril—Back pain—Docetaxel—head and neck cancer	0.00198	0.00219	CcSEcCtD
Lisinopril—Pain—Fluorouracil—head and neck cancer	0.00198	0.00219	CcSEcCtD
Lisinopril—Muscle spasms—Docetaxel—head and neck cancer	0.00197	0.00218	CcSEcCtD
Lisinopril—Nausea—Hydroxyurea—head and neck cancer	0.00191	0.00212	CcSEcCtD
Lisinopril—Feeling abnormal—Fluorouracil—head and neck cancer	0.00191	0.00211	CcSEcCtD
Lisinopril—Anaemia—Docetaxel—head and neck cancer	0.0019	0.0021	CcSEcCtD
Lisinopril—Urticaria—Fluorouracil—head and neck cancer	0.00184	0.00204	CcSEcCtD
Lisinopril—Syncope—Docetaxel—head and neck cancer	0.00184	0.00203	CcSEcCtD
Lisinopril—Leukopenia—Docetaxel—head and neck cancer	0.00184	0.00203	CcSEcCtD
Lisinopril—Body temperature increased—Fluorouracil—head and neck cancer	0.00183	0.00203	CcSEcCtD
Lisinopril—Palpitations—Docetaxel—head and neck cancer	0.00181	0.002	CcSEcCtD
Lisinopril—Loss of consciousness—Docetaxel—head and neck cancer	0.0018	0.00199	CcSEcCtD
Lisinopril—Cough—Docetaxel—head and neck cancer	0.00179	0.00198	CcSEcCtD
Lisinopril—Myalgia—Docetaxel—head and neck cancer	0.00175	0.00193	CcSEcCtD
Lisinopril—Arthralgia—Docetaxel—head and neck cancer	0.00175	0.00193	CcSEcCtD
Lisinopril—Chest pain—Docetaxel—head and neck cancer	0.00175	0.00193	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00173	0.00192	CcSEcCtD
Lisinopril—Hypersensitivity—Fluorouracil—head and neck cancer	0.00171	0.00189	CcSEcCtD
Lisinopril—Dry mouth—Docetaxel—head and neck cancer	0.00171	0.00189	CcSEcCtD
Lisinopril—Confusional state—Docetaxel—head and neck cancer	0.00169	0.00187	CcSEcCtD
Lisinopril—Anaphylactic shock—Docetaxel—head and neck cancer	0.00167	0.00185	CcSEcCtD
Lisinopril—Oedema—Docetaxel—head and neck cancer	0.00167	0.00185	CcSEcCtD
Lisinopril—Infection—Docetaxel—head and neck cancer	0.00166	0.00184	CcSEcCtD
Lisinopril—Shock—Docetaxel—head and neck cancer	0.00165	0.00182	CcSEcCtD
Lisinopril—Pruritus—Fluorouracil—head and neck cancer	0.00164	0.00181	CcSEcCtD
Lisinopril—Thrombocytopenia—Docetaxel—head and neck cancer	0.00164	0.00181	CcSEcCtD
Lisinopril—Tachycardia—Docetaxel—head and neck cancer	0.00163	0.00181	CcSEcCtD
Lisinopril—Skin disorder—Docetaxel—head and neck cancer	0.00163	0.0018	CcSEcCtD
Lisinopril—ACE—lymph node—head and neck cancer	0.00162	0.017	CbGeAlD
Lisinopril—Anorexia—Docetaxel—head and neck cancer	0.0016	0.00176	CcSEcCtD
Lisinopril—Diarrhoea—Fluorouracil—head and neck cancer	0.00159	0.00175	CcSEcCtD
Lisinopril—Hypotension—Docetaxel—head and neck cancer	0.00156	0.00173	CcSEcCtD
Lisinopril—Dizziness—Fluorouracil—head and neck cancer	0.00153	0.0017	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00153	0.00169	CcSEcCtD
Lisinopril—Insomnia—Docetaxel—head and neck cancer	0.00151	0.00167	CcSEcCtD
Lisinopril—Paraesthesia—Docetaxel—head and neck cancer	0.0015	0.00166	CcSEcCtD
Lisinopril—Dyspnoea—Docetaxel—head and neck cancer	0.00149	0.00165	CcSEcCtD
Lisinopril—Somnolence—Docetaxel—head and neck cancer	0.00149	0.00164	CcSEcCtD
Lisinopril—Vomiting—Fluorouracil—head and neck cancer	0.00147	0.00163	CcSEcCtD
Lisinopril—Dyspepsia—Docetaxel—head and neck cancer	0.00147	0.00163	CcSEcCtD
Lisinopril—Rash—Fluorouracil—head and neck cancer	0.00146	0.00162	CcSEcCtD
Lisinopril—Dermatitis—Fluorouracil—head and neck cancer	0.00146	0.00161	CcSEcCtD
Lisinopril—Decreased appetite—Docetaxel—head and neck cancer	0.00146	0.00161	CcSEcCtD
Lisinopril—Headache—Fluorouracil—head and neck cancer	0.00145	0.00161	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00145	0.0016	CcSEcCtD
Lisinopril—Fatigue—Docetaxel—head and neck cancer	0.00144	0.0016	CcSEcCtD
Lisinopril—Pain—Docetaxel—head and neck cancer	0.00143	0.00158	CcSEcCtD
Lisinopril—Constipation—Docetaxel—head and neck cancer	0.00143	0.00158	CcSEcCtD
Lisinopril—Feeling abnormal—Docetaxel—head and neck cancer	0.00138	0.00152	CcSEcCtD
Lisinopril—Nausea—Fluorouracil—head and neck cancer	0.00138	0.00152	CcSEcCtD
Lisinopril—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00137	0.00151	CcSEcCtD
Lisinopril—Abdominal pain—Docetaxel—head and neck cancer	0.00132	0.00146	CcSEcCtD
Lisinopril—Body temperature increased—Docetaxel—head and neck cancer	0.00132	0.00146	CcSEcCtD
Lisinopril—ABCB1—epithelium—head and neck cancer	0.00131	0.0138	CbGeAlD
Lisinopril—Hypersensitivity—Docetaxel—head and neck cancer	0.00123	0.00136	CcSEcCtD
Lisinopril—Asthenia—Docetaxel—head and neck cancer	0.0012	0.00133	CcSEcCtD
Lisinopril—Pruritus—Docetaxel—head and neck cancer	0.00118	0.00131	CcSEcCtD
Lisinopril—ABCB1—trachea—head and neck cancer	0.00116	0.0122	CbGeAlD
Lisinopril—Diarrhoea—Docetaxel—head and neck cancer	0.00115	0.00127	CcSEcCtD
Lisinopril—Dizziness—Docetaxel—head and neck cancer	0.00111	0.00122	CcSEcCtD
Lisinopril—Vomiting—Docetaxel—head and neck cancer	0.00106	0.00118	CcSEcCtD
Lisinopril—Rash—Docetaxel—head and neck cancer	0.00106	0.00117	CcSEcCtD
Lisinopril—Dermatitis—Docetaxel—head and neck cancer	0.00105	0.00117	CcSEcCtD
Lisinopril—Headache—Docetaxel—head and neck cancer	0.00105	0.00116	CcSEcCtD
Lisinopril—ABCB1—lymphoid tissue—head and neck cancer	0.00101	0.0106	CbGeAlD
Lisinopril—Nausea—Docetaxel—head and neck cancer	0.000994	0.0011	CcSEcCtD
Lisinopril—ABCB1—thyroid gland—head and neck cancer	0.000916	0.00962	CbGeAlD
Lisinopril—ABCB1—head—head and neck cancer	0.000813	0.00854	CbGeAlD
Lisinopril—ABCB1—lymph node—head and neck cancer	0.000569	0.00598	CbGeAlD
